Hanall to expand plant for annual 200 BW of production capacity.

Published: 2006-03-09 06:59:00

Updated: 2006-03-09 06:59:00

Hanall pharmaceutical company said on March 3 that because of the sales increases in the overseas markets and more new product development, the company needed to construct additional plant at 400-1 Sangseo dong Daedeok-ku, Daejon city where an annual 200 billion won of production could be covered...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK